Published the monthly exercise status for the 19th stock acquisition rights for October 2026 issued by third-party allotment. Of 2,320,000 shares delivered, 23,200 stock acquisition rights were exercised, representing 9.7% of the total issued, and unexercised rights at month-end amounted to 43,800. Compliance with exercise restrictions shows an exercise ratio of 2.4%, with 96,334,098 listed shares.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4883","jir_company_name":"Modalis Therapeutics Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4883-20261102-01.pdf","jir_short_summary":"Published the monthly exercise status for the 19th stock acquisition rights for October 2026 issued by third-party allotment. Of 2,320,000 shares delivered, 23,200 stock acquisition rights were exercised, representing 9.7% of the total issued, and unexercised rights at month-end amounted to 43,800. Compliance with exercise restrictions shows an exercise ratio of 2.4%, with 96,334,098 listed shares.","jir_summary":"### Overview of the Event\nThis publication reports the monthly exercise status for October 2026 of the 19th stock acquisition rights issued by third-party allotment. The number of shares delivered in the target month was 2,320,000 shares; 23,200 stock acquisition rights were exercised during the month, representing 9.7% of the total issued. Unexercised rights at the end of the previous month were 67,000 cases, and unexercised rights at month-end were 43,800 cases. The compliance with exercise restrictions shows an exercise ratio of 2.4%, and the number of listed shares is 96,334,098 shares.\n\n### Impact on Investors and Background\nMonthly exercise status of stock acquisition rights can be an indicator of dilution progression; however, the current exercise ratio is a single-digit percentage of total issued rights, and the near-term impact on share dilution is considered limited. Exercise dates are not specified, and details of individual transactions are limited to the published data. Continued disclosures will need to be monitored to assess exercise trends and impacts on capital structure.","jir_financial_highlights":"Number of shares delivered in the target month: 2,320,000 shares (Unknown)\nNumber of stock acquisition rights exercised in the target month: 23,200 cases (Unknown)\nProportion of exercised stock acquisition rights (to total issued): 9.7% (Unknown)\nUnexercised stock acquisition rights (at end of previous month): 67,000 cases (Unknown)\nUnexercised stock acquisition rights (at month-end): 43,800 cases (Unknown)\nCompliance with exercise restrictions (exercise ratio): 2.4% (Unknown)","jir_category":"","jir_hashtags":"#CompanyStockAcquisitionRights, #StockAcquisitionRights, #DisclosureUpdate","jir_key_figures":"Number of shares delivered: 2,320,000 shares\nNumber of stock acquisition rights exercised: 23,200 cases\nTotal issued: 240,000 cases\nUnexercised rights (end of previous month): 67,000 cases\nUnexercised rights (month-end): 43,800 cases\nExercise ratio: 2.4%\nListed shares: 96,334,098 shares\nOutstanding shares (target month): 113,634,098 shares (of which treasury stock 64 shares)","jir_meta_title":"Modalis Therapeutics Corporation: Monthly Exercise Status of Stock Acquisition Rights Announced | October 2026","jir_meta_description":"Modalis Therapeutics Corporation announces the October 2026 monthly exercise status for the 19th stock acquisition rights issued by third-party allotment. Delivered shares: 2,320,000 shares; exercised: 23,200 cases; 9.7% of total issued; unexercised: 43,800 cases; exercise restriction compliance: 2.4%.","jir_og_title":"Modalis Therapeutics Corporation Announces Monthly Exercise Status of Stock Acquisition Rights | October 2026","jir_og_description":"Modalis Therapeutics Corporation has published the October exercise status of the 19th stock acquisition rights: of 2,320,000 shares delivered, 23,200 cases were exercised and 43,800 cases remain unexercised. Dilution impact is considered limited.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60005,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-140100","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n